Menopause Management Beyond HRT: Evidence-Based Alternatives for Symptomatic Patients
Vasomotor Symptoms (VMS) can affect every aspect of a menopausal patient’s life, disrupting their sleep quality, impacting work productivity and draining daily energy levels. While many patients opt for Hormone Replacement Therapy (HRT) to mitigate symptoms, those with contraindications or personal preferences against it pose the dilemma of finding a safe, effective alternative.
Evidence-based alternatives, such as neurokinin-3 receptor (NK3R) antagonists, prescription medications and cognitive behavioral therapy (CBT), offer symptom relief without the need for systemic hormone exposure. Let’s explore the most effective options available and how they can help symptomatic patients improve their quality of life while keeping vasomotor symptoms under control.
Neurokinin 3 (NK3) Receptor Antagonists
Fezolinetant, marketed as Veozah, is a non-hormonal neurokinin-3 receptor antagonist that reduces the frequency and intensity of hot flashes by blocking the binding of Neurokinin B (NKB) to the NK3 receptor on kisspeptin, neurokinin B and dynorphin neurons in the hypothalamus. Modulating this thermoregulatory pathway helps stabilize the body’s temperature control center and reduce sudden heat surges that drive hot flashes.
Clinical trials have shown superior efficacy compared with placebo, with symptom reduction often observed within the first week of treatment. Studies support safe use up to 52 weeks, with serious adverse effects uncommon in most patients. The medication has been associated with elevations in liver enzymes, making hepatic monitoring and periodic liver function tests important for regular evaluation.
Non-Hormonal Prescription Agents
Several SSRIs and SNRIs have been approved for the reduction of vasomotor symptoms in patients who can’t or prefer not to use hormone therapy. Treatments are selected based on symptom patterns, comorbidities and patient preference, with common options including:
- Paroxetine: An SSRI approved by the FDA for the treatment of moderate to severe vasomotor symptoms, shown to reduce hot flash frequency and severity.
- Venlafaxine: An SNRI that’s demonstrated reductions in hot flash intensity and supports mood regulation during menopause.
- Gabapentin: Typically taken at bedtime, gabapentin can reduce night sweats and improve sleep quality.
- Pregabalin: Similar to gabapentin, pregabalin has been shown to decrease vasomotor symptom frequency and severity.
- Oxybutynin: An anticholinergic agent used off-label for patients with severe hot flashes, with routine monitoring necessary for anticholinergic side effects.
Cognitive Behavioral Therapy (CBT)
The North American Menopause Society (NAMS) recommends Cognitive Behavioral Therapy as an evidence-based, non-hormonal treatment for vasomotor symptoms. MENOS1 and MENOS2 protocols have been shown to reduce the “bother” factor of hot flashes, night sweats and insomnia by modifying the thoughts and behaviors that trigger or worsen symptoms. Patients can access CBT through digital therapeutics and apps, making it an easily accessible, effective treatment for those searching for symptom relief without medication.
Supplements and Botanicals: What Does the Data Say?
While supplements such as black cohosh, red clover and soy isoflavones are commonly used by patients seeking non-hormonal relief, they’re not highly effective in treating vasomotor symptoms. Clinical studies often show only mild improvements over placebos, with potential safety concerns and drug interactions posing a serious concern.
Black cohosh specifically has been linked to rare cases of liver injury and may interact with high blood pressure, cancer and depression medications. Regular monitoring and alternative treatment options are recommended to ensure safe, effective symptom reduction.
Personalized Treatment Plans for Menopause Management
Working with patients to understand their preferences, medical history and current symptoms helps create a safe, effective treatment plan that reduces vasomotor symptoms. Building a toolbox of options, including non-hormonal medications, NK3R antagonists and CBT therapy, helps patients explore strategies tailored to their unique needs. By taking a personalized approach, every patient can leave with a clear, actionable plan to manage menopausal symptoms and improve their quality of life.
Explore Oakstone’s CME courses and clinical resources for more information on evidence-based menopause management options. Pick your speciality and start exploring today to find products tailored to your learning needs.